Trial intelligence / Profile preview

Effect of nebulized bicarbonate on airway bacterial infections in cystic fibrosis

2016-004033-25Phase 2Completed

Sponsor
Fundació Parc Taulí
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of sodium bicarbonate in cystic fibrosis (CF) and Airways Infection (2 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Number of sputum cultures positive for Pseudomonas aeruginosa. Started Mar 2017; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

cystic fibrosis (CF)Airways Infection

Beyond the preview

Go deeper on 2016-004033-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004033-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call